Segall Bryant & Hamill’s Teladoc Health TDOC Stock Holding History

Segall Bryant & Hamill’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-4,424	Closed	-$686K	–	818
2020 Q1	$686K	Sell	4,424 -18,119	-80%	-$2.11M	0.01%	516
2019 Q4	$1.89M	Sell	22,543 -1,668	-7%	-$127K	0.03%	400
2019 Q3	$1.64M	Buy	24,211 +99	+0.4%	+$6.52K	0.03%	439
2019 Q2	$1.6M	Buy	24,112 +101	+0.4%	+$5.89K	0.02%	445
2019 Q1	$1.33M	Buy	24,011 +644	+3%	+$39.3K	0.02%	486
2018 Q4	$1.16M	Sell	23,367 -595	-2%	-$36.4K	0.02%	499
2018 Q3	$2.07M	Sell	23,962 -248	-1%	-$17.7K	0.03%	428
2018 Q2	$1.41M	Buy	+24,210	New	+$1.18M	0.02%	488

Other funds holding TDOC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Segall Bryant & Hamill's TDOC Position: Q2 2020 in Review

Segall Bryant & Hamill sold out of Teladoc Health (TDOC) in Q2 2020, closing a stake of 4,424 shares — an estimated $686K sold.

Segall Bryant & Hamill first reported a position in TDOC in Q2 2018 and held it in 8 quarters. The position peaked at $2.07M in Q3 2018. 670 funds tracked by Wall St. Rank hold TDOC as of Q2 2020.

Segall Bryant & Hamill reported no remaining Teladoc Health position as of Q2 2020 after selling out during the quarter.
Segall Bryant & Hamill sold 4,424 Teladoc Health shares in Q2 2020, an estimated $686K.
Segall Bryant & Hamill first reported a position in Teladoc Health in Q2 2018 and held it in 8 quarters.
Segall Bryant & Hamill's Teladoc Health position peaked at $2.07M in Q3 2018.
670 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2020.

Based on Segall Bryant & Hamill's 13F filing for Q2 2020, filed 14 Aug 2020.